TECHBio-Techne Corp.

CSNasdaq (XNAS)·USD

Identity

Security key: 22407
Ticker: TECH
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 1989-05-08
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: TECH

Detail

Enriched 2026-08-14 20:47

Market cap: $11,254,203,393.96
Shares outstanding (class): 156,568,751
Shares outstanding (weighted): 155,810,652
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 3,100
Location: MINNEAPOLIS, MN
Homepage: https://www.bio-techne.com
Description: Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Market cap and share counts drift.

Funds holding this security

361 funds · 367 positions · $2.77B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$260.21M	0.01%	4,979,128 NS	FIGI
Eaton Vance Atlanta Capital SMID-Cap Fund Eaton Vance Growth Trust	—	$207.64M	2.11%	3,973,154 NS	FIGI
VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS	VOO	$207.61M	0.01%	3,972,597 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$188.52M	0.11%	3,607,369 NS	FIGI
SMALLCAP World Fund Inc SMALLCAP World Fund Inc	—	$151.13M	0.19%	2,891,811 NS	FIGI
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$105.57M	0.27%	2,020,017 NS	FIGI
iShares Core S&P 500 ETF iShares Trust	IVV	$104.90M	0.01%	2,007,240 NS	FIGI
Fidelity Contrafund Fidelity Contrafund	—	$101.26M	0.06%	1,937,621 NS	FIGI
N/A —	—	$95.17M	0.01%	1,821,062 NS	FIGI
Mairs & Power Growth Fund Trust for Professional Managers	—	$73.74M	1.47%	1,411,001 NS	FIGI
T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC.	—	$73.27M	0.57%	1,401,962 NS	FIGI
Sequoia Fund Inc Sequoia Fund Inc	—	$68.11M	2.05%	1,303,294 NS	FIGI
Nomura Mid Cap Growth Fund IVY FUNDS	—	$64.55M	2.15%	1,235,246 NS	FIGI
First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund	FBT	$64.15M	2.83%	1,227,575 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$60.20M	0.74%	1,151,950 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERTECH
FIGI_COMPOSITEBBG000C15114
FIGI_SHARE_CLASSBBG001S66C28
CIK0000842023
ISINUS09073M1045
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Life Sciences Tools
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Bio-Techne is a life science tools company providing reagents and instruments for research and diagnostics.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.